Sangamo Therapeutics SGMOQ
OTC SGMOQ
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sangamo Therapeutics (SGMOQ) Selling, General & Administrative (2010 - 2025)

Updated

Sangamo Therapeutics (SGMOQ) posted Selling, General & Administrative of $7.76 million for Q4 2025, down 21.4% from $9.87 million a year earlier and down 2.9% from the prior quarter.

Analysis

Sangamo Therapeutics (SGMOQ) Selling, General & Administrative (2010 - 2025) Analysis & Trends

For FY2025, Sangamo Therapeutics' Selling, General & Administrative came in at $34.89 million, down 22.0% from FY2024.

  • Annual Selling, General & Administrative has declined for five consecutive years, with a five-year compound annual growth rate of -12.3% (FY2020 to FY2025).
  • In prior years, Sangamo Therapeutics' Selling, General & Administrative was $44.73 million in FY2024 (-26.9%), $61.17 million in FY2023 (-2.4%), $62.68 million in FY2022 (-0.8%) and $63.22 million in FY2021 (-5.8%).
  • The Q4 2025 figure stands as the lowest quarterly Selling, General & Administrative since Q4 2017.
  • On a year-over-year basis, Selling, General & Administrative has declined in each of the last ten quarters, with an average decline of 24.2% over the last eight quarters.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q1 2023, with growth of 21.7%; the weakest was Q1 2024, with a decline of 35.1%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $7.99 million (Q3 2025), $9.08 million (Q2 2025) and $10.06 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Sangamo Therapeutics 42.03 Mn -72.08 Mn - 7.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 7.76 Mn
Sep 30, 2025 7.99 Mn
Jun 30, 2025 9.08 Mn
Mar 31, 2025 10.06 Mn
Dec 31, 2024 9.87 Mn
Sep 30, 2024 11.05 Mn
Jun 30, 2024 12.05 Mn
Mar 31, 2024 11.77 Mn
Dec 31, 2023 13.10 Mn
Sep 30, 2023 13.92 Mn
Jun 30, 2023 16.01 Mn
Mar 31, 2023 18.14 Mn
Dec 31, 2022 16.44 Mn
Sep 30, 2022 16.24 Mn
Jun 30, 2022 15.09 Mn
Mar 31, 2022 14.91 Mn
Dec 31, 2021 16.08 Mn
Sep 30, 2021 14.50 Mn
Jun 30, 2021 16.49 Mn
Mar 31, 2021 16.15 Mn
API Access

Sangamo Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY